These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20599225)

  • 1. Neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer.
    Kennedy CR; Gao F; Margenthaler JA
    J Surg Res; 2010 Sep; 163(1):52-7. PubMed ID: 20599225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features of early failure of neoadjuvant chemotherapy in locally advanced breast cancer.
    Choi MK; Park YH; Kil WH; Lee JE; Nam SJ; Ahn JS; Im YH
    Cancer Chemother Pharmacol; 2014 Sep; 74(3):521-9. PubMed ID: 25047725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in ER, PR and HER2 receptors status after neoadjuvant chemotherapy in breast cancer.
    Yang YF; Liao YY; Li LQ; Xie SR; Xie YF; Peng NF
    Pathol Res Pract; 2013 Dec; 209(12):797-802. PubMed ID: 24183366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
    Liedtke C; Mazouni C; Hess KR; André F; Tordai A; Mejia JA; Symmans WF; Gonzalez-Angulo AM; Hennessy B; Green M; Cristofanilli M; Hortobagyi GN; Pusztai L
    J Clin Oncol; 2008 Mar; 26(8):1275-81. PubMed ID: 18250347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of factors that influence the accuracy of magnetic resonance imaging for predicting response after neoadjuvant chemotherapy in locally advanced breast cancer.
    Ko ES; Han BK; Kim RB; Ko EY; Shin JH; Hahn SY; Nam SJ; Lee JE; Lee SK; Im YH; Park YH
    Ann Surg Oncol; 2013 Aug; 20(8):2562-8. PubMed ID: 23463090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance and prognostic value of receptor conversion in hormone receptor positive breast cancers after neoadjuvant chemotherapy.
    Yang L; Zhong X; Pu T; Qiu Y; Ye F; Bu H
    World J Surg Oncol; 2018 Mar; 16(1):51. PubMed ID: 29514654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are we Overtreating Hormone Receptor Positive Breast Cancer with Neoadjuvant Chemotherapy? Role of OncotypeDx
    Kantor O; Barrera E; Kopkash K; Pesce C; Barrera E; Winchester DJ; Yao K
    Ann Surg Oncol; 2019 Oct; 26(10):3232-3239. PubMed ID: 31342379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to neoadjuvant chemotherapy of aggressive breast cancer.
    Asano Y; Kashiwagi S; Goto W; Kurata K; Noda S; Takashima T; Onoda N; Tanaka S; Ohsawa M; Hirakawa K
    Br J Surg; 2016 Jun; 103(7):845-54. PubMed ID: 26953091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy for breast cancer increases the rate of breast conservation: results from the National Cancer Database.
    Killelea BK; Yang VQ; Mougalian S; Horowitz NR; Pusztai L; Chagpar AB; Lannin DR
    J Am Coll Surg; 2015 Jun; 220(6):1063-9. PubMed ID: 25868410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors and patterns of recurrence in patients with triple negative breast cancer.
    Steward L; Conant L; Gao F; Margenthaler JA
    Ann Surg Oncol; 2014 Jul; 21(7):2165-71. PubMed ID: 24558065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of breast magnetic resonance imaging clinical tumor size with pathologic tumor size in patients status post-neoadjuvant chemotherapy.
    Williams M; Eatrides J; Kim J; Talwar H; Esposito N; Szabunio M; Ismail-Khan R; Kiluk J; Lee M; Laronga C; Khakpour N
    Am J Surg; 2013 Oct; 206(4):567-73. PubMed ID: 23809673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy and differential invasive breast cancer specific survival in elderly women.
    Kaplan HG; Malmgren JA; Atwood MK
    J Geriatr Oncol; 2013 Apr; 4(2):148-56. PubMed ID: 24071540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma.
    Cimino-Mathews A; Verma S; Figueroa-Magalhaes MC; Jeter SC; Zhang Z; Argani P; Stearns V; Connolly RM
    Am J Clin Pathol; 2016 Mar; 145(3):365-72. PubMed ID: 27124919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MET expression is associated with disease-specific survival in breast cancer patients in the neoadjuvant setting.
    Koh YW; Lee HJ; Ahn JH; Lee JW; Gong G
    Pathol Res Pract; 2014 Aug; 210(8):494-500. PubMed ID: 24814255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinoma.
    Castaneda CA; Flores R; Rojas K; Flores C; Castillo M; Milla E
    Hematol Oncol Stem Cell Ther; 2014 Dec; 7(4):149-56. PubMed ID: 25300565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons' Referrals.
    Mamounas E; Poulos C; Goertz HP; González JM; Pugh A; Antao V
    Ann Surg Oncol; 2016 Oct; 23(11):3510-3517. PubMed ID: 27283292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Pathological Complete Response to Neoadjuvant Chemotherapy in Iranian Breast Cancer Patients.
    Sasanpour P; Sandoughdaran S; Mosavi-Jarrahi A; Malekzadeh M
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2423-2427. PubMed ID: 30255695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of neoadjuvant chemotherapy on surgical outcomes among patients with hormone receptor positive breast cancer.
    Hage AN; Capriccioso C; Brennan J; Heiden B; Zheutlin A; Sabel MS
    J Surg Oncol; 2017 Nov; 116(6):665-670. PubMed ID: 28672101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI evaluation of residual breast cancer after neoadjuvant chemotherapy: influence of patient, tumor and chemotherapy characteristics on the correlation with pathological response.
    Diguisto C; Ouldamer L; Arbion F; Vildé A; Body G
    Anticancer Res; 2015 Jan; 35(1):581-5. PubMed ID: 25550606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of Treatment Response, Tumor Grade and Receptor Status Improves Staging Quality in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Bergquist JR; Murphy BL; Storlie CB; Habermann EB; Boughey JC
    Ann Surg Oncol; 2017 Nov; 24(12):3510-3517. PubMed ID: 28828583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.